BIOMARIN PHARMACEUTICAL INC - NOTE 0.750%10/1

Historical Holders from Q1 2014 to Q4 2018

Type / Class
Debt / NOTE 0.750%10/1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 0.750%10/1 across Reporting Periods

Period Principal Value Change Price Investors
2018 Q4 0 $0 -$362,053,297 0
2018 Q3 350,274,000 $362,052,099 +$17,703,864 $1.03 35
2018 Q2 330,463,000 $351,061,548 -$2,959,384 $1.06 48
2018 Q1 333,743,000 $342,378,063 -$19,490,677 $1.02 43
2017 Q4 338,755,000 $367,571,182 -$11,587,554 $1.08 42
2017 Q3 348,838,000 $389,828,244 +$10,077,647 $1.12 43
2017 Q2 340,031,200 $380,830,000 -$2,409,137 $1.11 47
2017 Q1 340,484,200 $386,409,638 -$7,779,379 $1.13 41
2016 Q4 354,439,200 $404,099,000 -$18,499,909 $1.12 40
2016 Q3 374,476,000 $449,657,000 -$2,656,918 $1.20 43
2016 Q2 351,282,002 $390,766,002 -$3,111,124 $1.11 44
2016 Q1 378,910,533 $438,219,000 +$12,225,572 $1.16 48
2015 Q4 367,076,000 $472,735,000 -$7,642,414 $1.28 42
2015 Q3 363,935,000 $473,515,000 -$1,588,875 $1.29 53
2015 Q2 359,575,832 $557,009,293 +$70,479,216 $1.54 53
2015 Q1 311,455,000 $462,822,000 +$55,099,014 $1.49 50
2014 Q4 276,560,709 $326,738,837 -$49,629,285 $1.18 45
2014 Q3 323,889,000 $344,206,000 +$3,548,852 $1.06 45
2014 Q2 320,654,000 $333,253,000 +$53,183,855 $1.03 43
2014 Q1 240,454,000 $263,492,000 -$17,153,209 $1.10 33